Atlas Trials

Phase II Study With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With Gastric Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Clinical trial NCT00204659 · COMPLETED

Trial details

NCT number
NCT00204659
Sponsor
University Hospital Tuebingen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Primary Gastric Diffuse-Large B-Cell Lymphoma
Start date
2003-03-01
Primary completion
2008-09-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.